Non-alcoholic fatty liver disease (NAFLD): assessment and management
National Institute for Health and Care Excellence
Non-alcoholic fatty liver disease (NAFLD) has an estimated prevalence of between 20–30% of the general population and is increasing. While the average age of people with NAFLD-related non-alcoholic steatohepatitis is around 40–50 years, the growth of childhood obesity has increased the number of younger people with NAFLD, with some prevalence studies showing that up to 38% of obese children have evidence of NAFLD. With no currently licensed treatment and the falling average age of diagnosis, early detection and management of NAFLD in primary and secondary care is crucial.
This Guidelines summary provides recommendations on identification and diagnosis, and includes an algorithm on the assessment and monitoring of NAFLD in adults, children, and young people.